Eric Rosenthal Reports

Eric T. Rosenthal - October 9, 2018

Eric T. Rosenthal - September 22, 2018

Eric T. Rosenthal - April 12, 2018

Eric T. Rosenthal - April 10, 2018

Eric T. Rosenthal - April 3, 2018

Peter Hofland, Ph.D - September 25, 2020

Peter Hofland, Ph.D - September 23, 2020

Editorial Team - September 22, 2020

Peter Hofland, Ph.D - September 22, 2020

Peter Hofland, Ph.D - September 21, 2020

Dracen Pharmaceuticals Announces the Initiation of First-in-human... September 25, 2020
DRP-104, the Company’s novel broad-acting glutamine antagonist, directly targets tumor metabolism and induces profound anti-tumor immune responses. Extensive Pre-clinical profiling supports single...(PRWeb September 25, 2020)Read the full story at https://www.prweb.com/releases/dracen_pharmaceuticals_announces_the_initiation_of_first_in_human_study_of_drp_104_in_adult_patients_with_advanced_solid_tumors/prweb17423191.htm
Uniform Advantage Donates $20,000 to the Breast Cancer Research... September 24, 2020
Uniform Advantage launches a breast cancer awareness campaign and donates $20,000 to the Breast Cancer Research Foundation in support of breast cancer research.(PRWeb September 24, 2020)Read the full story at https://www.prweb.com/releases/uniform_advantage_donates_20_000_to_the_breast_cancer_research_foundation_in_support_of_breast_cancer_research/prweb17419680.htm
Xstrahl Appoints Dr. Richard Shaffer as Medical Director September 24, 2020
Dr. Shaffer will help support the use of radiation therapy for skin cancer and benign disease(PRWeb September 24, 2020)Read the full story at https://www.prweb.com/releases/xstrahl_appoints_dr_richard_shaffer_as_medical_director/prweb17415571.htm